Dublin, Dec. 08, 2025 (GLOBE NEWSWIRE) -- The "Companion Animal Pharmaceuticals Market - Global Forecast 2025-2032" has been added to ResearchAndMarkets.com's offering. The Companion Animal ...
(MENAFN- GlobeNewsWire - Nasdaq) Key opportunities in the companion animal pharmaceuticals market include developing advanced biologics and targeted therapies driven by increased pet ownership and ...
No treatment-related adverse toxicity was observed across completed GLP studies, with consistent systemic exposure following ...
NDT Pharmaceuticals, Inc.’s (OTC: NDTP) wholly-owned subsidiary Good Salt Life, Inc., a pioneer in innovative surface ...
Exploring With Josh on MSN
What happened to Shigeta Animal Pharmaceuticals?
Shigeta Animal Pharmaceuticals, established in 1984 in Toyama Prefecture, was notable for developing the first canine/feline ...
Animal rights groups celebrate, but the Trump administration is light on specifics about phasing out federally funded medical ...
A rare moment of bipartisan progress has emerged with the Senate’s unanimous passage of the FDA Modernization Act 3.0, ...
Calgary Herald on MSNOpinion
Opinion: Animal health is key to national security and global diplomacy
When we think of national security, we picture armies, borders and intelligence services. Rarely do we think of veterinarians ...
Exploring clinical development plan options including a controlled human infection model (CHIM) and a Phase 2/3 adaptive ...
The healthcare industry has never been a great source of dividends -- that alone makes these companies exceptional.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback